Who owns LIPOCINE INC NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Lipocine with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lipocine stock

Who bought or sold LIPOCINE INC NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 222k $1.2M 0% Mar 2024
 View chart
BlackRock 75k $388k 0% Mar 2024
 View chart
Susquehanna International 60k $310k -47% Mar 2024
 View chart
Geode Capital Management 49k $254k 0% Mar 2024
 View chart
Two Sigma Advisers 26k $134k -2% Mar 2024
 View chart
Tower Research Capital 2.0k $11k 693% Mar 2024
 View chart
Morgan Stanley 722.00 $3.8k 0% Mar 2024
 View chart
Caldwell Sutter Capital 471.00 $2.4k 0% Mar 2024
 View chart
UBS Group 431.00 $2.2k 100% Mar 2024
 View chart
Advisor Group Holdings 68.00 $352.002000 0% Mar 2024
 View chart
Old Point Trust & Financial Services N A 59.00 $307.000600 100% Mar 2024
 View chart
Tidemark 59.00 $307.000600 0% Mar 2024
 View chart
Wells Fargo & Company 42.00 $218.001000 2% Mar 2024
 View chart
Group One Trading 40.00 $208.000000 -23% Mar 2024
 View chart
Royal Bank of Canada 14.00 $0 -85% Mar 2024
 View chart
Jpmorgan Chase & Co 12.00 $62.000400 33% Mar 2024
 View chart

Who sold out of Lipocine?

Fund or Company Name Date Sold Shares Held Valued At
Kestra Advisory Services Sep 2023 17k $50k
Wealth Effects Dec 2023 15k $41k
FMR Sep 2023 59.00 $172.999800